To construct a research group focused on utilizing artificial intelligence and bioinformatics for cardiooncology patients, a multi-institutional multidisciplinary team was formed. Cardio-oncology is a new medical discipline devoted to the prevention, detection, and management of cancer/cancer therapy-related adverse cardiovascular consequences. In cancer survivors, cardiovascular disease is the primary cause of death. These patients have a higher cardiovascular risk than the overall population. However, predicting and preventing unfavorable cardiovascular events in those who have had cancer or have had cancer therapy is difficult. As a result, it was deemed critical to form an interdisciplinary team to develop cardiovascular risk assessment health care decision aids for oncology patients that could be integrated into electronic health records.